AGXT Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
AGXT Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
MAOA Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
SHMT1 Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
GCAT Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
AGXT Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
DAO Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
GLDC Antibody - N-terminal region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
AOC3 Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
SHMT1 Antibody - N-terminal region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
AGXT Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
SHMT1 Antibody
Reactivities | Human |
Conjugation | Unconjugated |
AOC2 Antibody - middle region
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |